Company intelligence / Profile preview
Sino Biopharm
Beijing, Beijing, China
- Ownership
- Private
- Employees
- ~25579
- Development stage
- Other
01
Overview
Sino Biopharm is one of the largest pharmaceutical companies in China, focused on oncology, hepatology, and respiratory diseases, with multiple products approved and marketed. Anlotinib (targeting VEGFR, PDGFR, FGFR) is a well-known commercialized small molecule for cancer; Penpulimab is a commercialized monoclonal antibody for immuno-oncology. The company is also active in biosimilars, generic drugs, and modernized Chinese medicine, with recent expansion into biopharma platforms such as bispecific antibodies and mRNA delivery, especially through its subsidiary invoX[1][2][3][4][5].
- Therapeutic areas
- RheumatologyInfectious DiseasesGastroenterologyPulmonologyCardiovascularOncologyNeurology
- Modalities
- Small moleculeBiologicMonoclonal antibodyBispecific monoclonal antibodymRNA-based drugsAntibody-drug conjugate
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
China-Japan Friendship Hospital (Beijing Tide joint venture)F-star (bispecific antibody, via invoX acquisition)Softhale (soft mist inhalation, via invoX acquisition)pHion (mRNA delivery, via invoX acquisition)
Beyond the preview
Go deeper on Sino Biopharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sino Biopharm.